Publication | Closed Access

Safety and efficacy of oral semaglutide versus dulaglutide in Japanese patients with type 2 diabetes (PIONEER 10): an open-label, randomised, active-controlled, phase 3a trial

Diabetes ManagementCardiovascular DiseaseMedicineDiabetesClinical TrialsType 2Pioneer 10PharmacotherapyDiabetes MellitusPharmacologyJapanese Patients